Palimpsest Bio Corp.

New Filing

CIK: 0002162952·Biotechnology·DELAWARE·Filed: Oct 30, 2026

Total Offering

$1,000,000

Amount Sold

$172,000

Investors

4

First Sale

Jun 27, 2026

Offering Details

Type: Other: Simple Agreement for Future Equity (SAFE)
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2026
Non-Accredited Investors: No

Related Persons

Name	Role
Matthew Davin Korpela	Related Person

Company

Palimpsest Bio Corp.

4525 Dean Martin Dr.

Las Vegas, NV, 89103

414-310-9448

SEC Filing

0002162952-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.